Defunct Company
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
150
NCT02077543
Multicenter Safety Trial Assessing an Innovative Tumor Molecular and Cellular Print Medical Device in Glioma
Phase: Early Phase 1
Role: Collaborator
Start: Oct 31, 2013
Completion: Dec 31, 2020